Without Compulsary Licensing - Patients the World Over Will Pay the Price

This policy brief urges parliamentarians to implement systems that can safeguard public health such as compulsory licensing that blocks generic production by Indian companies and make drugs either unavailable or unaffordable across the developing world. It highlights the fact that patents will help to minimize prices for the essential drugs and make them affordable by eliminating competition. Compulsory licensing authorizes production of generic medicines only in the event of failure on the part of patent holder to comply with the obligations to make patented medicines available and affordable to patients.